CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)
China
· Delayed Price · Currency is CNY 29.94
-0.20 (-0.66%)
Apr 29, 2026, 3:06 PM CST
SHE:300765 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 41,694 | 50,231 | 37,029 | 42,873 | 9,767 | 8,376 | Upgrade
|
| Market Cap Growth | -19.88% | 35.65% | -13.63% | 338.97% | 16.61% | 6.59% | Upgrade
|
| Enterprise Value | 40,821 | 49,475 | 36,671 | 39,717 | 7,864 | 6,725 | Upgrade
|
| Last Close Price | 29.94 | 36.07 | 26.58 | 30.25 | 7.19 | 6.92 | Upgrade
|
| PE Ratio | - | - | 689.22 | 98.69 | 13.45 | 21.30 | Upgrade
|
| Forward PE | 41.16 | 102.68 | 51.60 | 50.21 | 12.60 | - | Upgrade
|
| PS Ratio | 17.74 | 23.28 | 18.69 | 16.89 | 3.72 | 4.53 | Upgrade
|
| PB Ratio | 15.61 | 17.97 | 8.24 | 7.82 | 2.48 | 2.54 | Upgrade
|
| P/TBV Ratio | 17.67 | 20.52 | 10.56 | 8.49 | 2.51 | 2.59 | Upgrade
|
| P/FCF Ratio | - | - | - | 306.85 | 18.54 | 86.64 | Upgrade
|
| P/OCF Ratio | - | - | - | 59.45 | 15.24 | 28.68 | Upgrade
|
| EV/Sales Ratio | 17.37 | 22.93 | 18.51 | 15.64 | 2.99 | 3.64 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 128.72 | 9.60 | 13.34 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 258.24 | 10.53 | 15.46 | Upgrade
|
| EV/FCF Ratio | -47.02 | - | - | 284.26 | 14.93 | 69.57 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.00 | 0 | 0 | 0.01 | 0 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 0.01 | 0.02 | 0.00 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.01 | 0.04 | 0.01 | Upgrade
|
| Net Debt / Equity Ratio | -0.36 | -0.49 | -0.38 | -0.69 | -0.55 | -0.50 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.59 | 3.37 | 28.14 | -12.21 | -2.66 | -3.29 | Upgrade
|
| Net Debt / FCF Ratio | 1.11 | 1.78 | 0.99 | -26.97 | -4.13 | -17.14 | Upgrade
|
| Asset Turnover | 0.38 | 0.35 | 0.29 | 0.42 | 0.63 | 0.55 | Upgrade
|
| Inventory Turnover | 3.31 | 2.98 | 3.71 | 5.98 | 5.97 | 5.59 | Upgrade
|
| Quick Ratio | 0.65 | 0.76 | 1.58 | 2.28 | 5.00 | 5.31 | Upgrade
|
| Current Ratio | 1.00 | 1.05 | 1.95 | 2.42 | 5.48 | 6.09 | Upgrade
|
| Return on Equity (ROE) | -16.98% | -16.71% | -6.08% | 2.67% | 20.07% | 13.12% | Upgrade
|
| Return on Assets (ROA) | -6.07% | -6.36% | -2.56% | 1.59% | 11.22% | 8.12% | Upgrade
|
| Return on Invested Capital (ROIC) | -38.05% | -29.56% | -12.26% | 4.23% | 37.41% | 24.92% | Upgrade
|
| Return on Capital Employed (ROCE) | -17.40% | -17.50% | -6.00% | 2.80% | 18.70% | 13.00% | Upgrade
|
| Earnings Yield | -0.74% | -0.48% | 0.14% | 1.01% | 7.44% | 4.70% | Upgrade
|
| FCF Yield | -2.08% | -1.52% | -4.63% | 0.33% | 5.39% | 1.15% | Upgrade
|
| Dividend Yield | 0.07% | - | 0.07% | 0.88% | 0.97% | 1.00% | Upgrade
|
| Payout Ratio | - | - | 696.42% | 22.52% | 11.30% | 10.68% | Upgrade
|
| Buyback Yield / Dilution | 0.54% | 0.44% | -0.16% | -4.50% | 0.02% | -13.53% | Upgrade
|
| Total Shareholder Return | 0.60% | 0.44% | -0.08% | -3.62% | 0.98% | -12.53% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.